Search Results | Cancer Research | American Association for Cancer Research

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Abstract 5366: The small molecule Bcl-2 antagonist obatoclax interacts synergistically with the irreversible proteasome inhibitor carfilzomib in GC and ABC- sub types of DLBCL cells both in vitro and in vivo

Girija P. Dasmahapatra, Dmitry Lembersky, Jonathan W. Friedberg, Richard I. Fisher, Paul Dent, Steven Grant

Cancer Res (2011) 71 (8_Supplement): 5366.

DOI: https://doi.org/10.1158/1538-7445.AM2011-5366

Published: 15 April 2011

View article

Journal Articles

Alteration of SMRT Tumor Suppressor Function in Transformed Non-Hodgkin Lymphomas

Lynda Song, Andrei Zlobin, Pushpankur Ghoshal, Qing Zhang, Christiane Houde, Sanne Weijzen, Qun Jiang, Elizabeth Nacheva, Danny Yagan, Eric Davis, Sylvie Galiegue-Zouitina, Daniel Catovsky, Thomas Grogan, Richard I. Fisher, Lucio Miele, Lionel J. Coignet

Cancer Res (2005) 65 (11): 4554–4561.

DOI: https://doi.org/10.1158/0008-5472.CAN-04-4108

Published: 01 June 2005

View article

Journal Articles

Identification of a Novel CD56^- Lymphokine-activated Killer Cell Precursor in Cancer Patients Receiving Recombinant Interleukin 2

R. Scott McKenzie, Patricia E. Simms, Barbara A. Helfrich, Richard I. Fisher, Thomas M. Ellis

Cancer Res (1992) 52 (22): 6318–6322.

Published: 01 November 1992

View article

Journal Articles

1-β-d-Arabinofuranosylcytosine and Hydroxyurea Production of Cytotoxic Synergy with cis-Diamminedichloroplatinum(II) and Modification of Platinum-induced DNA Interstrand Cross-Linking¹

Lode J. Swinnen, Diane M. Barnes, Susan G. Fisher, Kathy S. Albain, Richard I. Fisher, Leonard C. Erickson

Cancer Res (1989) 49 (6): 1383–1389.

Published: 01 March 1989

View article

Journal Articles

Appearance and Phenotypic Characterization of Circulating Leu 19+ Cells in Cancer Patients Receiving Recombinant Interleukin 2

Thomas M. Ellis, Stephen P. Creekmore, John D. McMannis, Donald P. Braun, Jules A. Harris, Richard I. Fisher

Cancer Res (1988) 48 (22): 6597–6602.

Published: 01 November 1988

View article

Journal Articles

Diversity of Immunological Phenotypes of Lymphoblastic Lymphoma

Jeffrey Cossman, Thomas M. Chused, Richard I. Fisher, Ian Magrath, Frederick Bollum, Elaine S. Jaffe

Cancer Res (1983) 43 (9): 4486–4490.

Published: 01 September 1983

View article

Journal Articles

Association of the Human Type C Retrovirus with a Subset of Adult T-Cell Cancers

Cancer Res (1983) 43 (8): 3892–3899.

Published: 01 August 1983

View article

Journal Articles

Objective Regressions of T- and B-Cell Lymphomas in Patients following Treatment with Anti-Thymocyte Globulin

Richard I. Fisher, Bruce A. Silver, Christian P. Vanhaelen, Elaine S. Jaffe, Jeffrey Cossman

Cancer Res (1982) 42 (6): 2465–2469.

Published: 01 June 1982

View article

Journal Articles

Controlled Clinical Trials of Nutritional Intervention as an Adjunct to Chemotherapy, with a Comment on Nutrition and Drug Resistance

Arthur S. Levine, Murray F. Brennan, Avner Ramu, Richard I. Fisher, Philip A. Pizzo, Daniel L. Glaubiger

Cancer Res (1982) 42 (2_Supplement): 774s–778s.

Published: 01 February 1982

View article

Journal Articles

Lack of Histocompatibility Antigens on a Murine Ovarian Teratocarcinoma

Christian P. J. Vanhaelen, Richard I. Fisher, Ettore Appella, Lata Ramanathan

Cancer Res (1981) 41 (8): 3186–3191.

Published: 01 August 1981

View article

Journal Articles

Requirements for Successful Immunotherapy and Chemoimmunotherapy of a Murine Model of Ovarian Cancer

Christian P. J. Vanhaelen, Richard I. Fisher

Cancer Res (1981) 41 (3): 980–983.

Published: 01 March 1981

View article

Journal Articles

Kinetic Characterization and Response to Chemotherapy in a Transplantable Murine Ovarian Cancer

Robert F. Ozols, Karen R. Grotzinger, Richard I. Fisher, Charles E. Myers, Robert C. Young

Cancer Res (1979) 39 (8): 3202–3208.

Published: 01 August 1979

View article

NARROW

Abstract 5366: The small molecule Bcl-2 antagonist obatoclax interacts synergistically with the irreversible proteasome inhibitor carfilzomib in GC and ABC- sub types of DLBCL cells both in vitro and in vivo

Alteration of SMRT Tumor Suppressor Function in Transformed Non-Hodgkin Lymphomas

Identification of a Novel CD56^- Lymphokine-activated Killer Cell Precursor in Cancer Patients Receiving Recombinant Interleukin 2

1-β-d-Arabinofuranosylcytosine and Hydroxyurea Production of Cytotoxic Synergy with cis-Diamminedichloroplatinum(II) and Modification of Platinum-induced DNA Interstrand Cross-Linking¹

Appearance and Phenotypic Characterization of Circulating Leu 19+ Cells in Cancer Patients Receiving Recombinant Interleukin 2

Diversity of Immunological Phenotypes of Lymphoblastic Lymphoma

Association of the Human Type C Retrovirus with a Subset of Adult T-Cell Cancers

Objective Regressions of T- and B-Cell Lymphomas in Patients following Treatment with Anti-Thymocyte Globulin

Controlled Clinical Trials of Nutritional Intervention as an Adjunct to Chemotherapy, with a Comment on Nutrition and Drug Resistance

Lack of Histocompatibility Antigens on a Murine Ovarian Teratocarcinoma

Requirements for Successful Immunotherapy and Chemoimmunotherapy of a Murine Model of Ovarian Cancer

Kinetic Characterization and Response to Chemotherapy in a Transplantable Murine Ovarian Cancer

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only